# PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy

> **NCT02035683** · NA · UNKNOWN · sponsor: **National Cancer Institute, Naples** · enrollment: 220 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic
- Non-small Cell Lung Cancer Stage IIIB

## Interventions

- **PROCEDURE:** PET/CT

## Key facts

- **NCT ID:** NCT02035683
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02035683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02035683, "PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02035683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*